Kiniksa Pharmaceuticals Ltd Financial Flexibility Index
Kiniksa Pharmaceuticals Ltd financial flexibility index. Kiniksa Pharmaceuticals Ltd (KNSA) has a Financial Flexibility Index of 0.20x as of June 2026. Free cash flow of $48.12 Million (operating CF $47.46 Million minus capex $663.00K) represents 0% of total liabilities ($241.96 Million). See Kiniksa Pharmaceuticals Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kiniksa Pharmaceuticals Ltd (2016–2025)
Financial flexibility index of Kiniksa Pharmaceuticals Ltd from 2016 to 2025. Historical Financial Flexibility Index trend for Kiniksa Pharmaceuticals Ltd across 10 annual periods. Check KNSA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Kiniksa Pharmaceuticals Ltd Financial Flexibility Index by Year (2016–2025)
Kiniksa Pharmaceuticals Ltd financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Kiniksa Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Kiniksa Pharmaceuticals Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | $25.97 Million | $25.69 Million | $196.03 Million | ▼ -27.5% |
| 2024 | 0.18x | $25.97 Million | $25.69 Million | $142.12 Million | ▲ +19.0% |
| 2023 | 0.15x | $13.43 Million | $13.30 Million | $87.48 Million | ▲ +65.0% |
| 2022 | 0.09x | $5.91 Million | $5.81 Million | $63.52 Million | ▲ +104.2% |
| 2021 | -2.22x | $-105.88 Million | $-126.30 Million | $47.76 Million | ▲ +38.9% |
| 2020 | -3.63x | $-136.25 Million | $-136.53 Million | $37.53 Million | ▲ +31.9% |
| 2019 | -5.33x | $-155.17 Million | $-158.37 Million | $29.11 Million | ▼ -200.6% |
| 2018 | -1.77x | $-75.72 Million | $-81.01 Million | $42.70 Million | ▼ -385.2% |
| 2017 | -0.37x | $-50.15 Million | $-50.22 Million | $137.20 Million | ▼ -37.4% |
| 2016 | -0.27x | $-21.86 Million | $-21.87 Million | $82.20 Million | — |